Related Experiment Video
Updated: May 23, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Bcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch
1University of Kansas, Department of Molecular Biosciences Lawrence, Kansas, USA. rtmarquez@ku.edu; xul@ku.edu
Abstract:
Cancer cells have developed novel mechanisms for evading chemotherapy-induced apoptosis and autophagy-associated cell death pathways. Upon the discovery that chemotherapeutics could target these cell death pathways in a manner that was not mutually exclusive, new discoveries about the interrelationship between these two pathways are emerging. Key proteins originally thought to be "autophagy-related proteins" are now found to be involved in either inducing or inhibiting apoptosis. Similarly, apoptosis inhibiting proteins can also block autophagy-associated cell death. One example is the complex formed by the autophagy protein, Beclin 1, and anti-apoptotic protein Bcl-2, which leads to inhibition of autophagy-associated cell death. Researchers have been investigating additional mechanisms that form/disrupt this complex in order to better design chemotherapeutics. This review will highlight the role Bcl-2 and Beclin 1 play in cancer development and drug resistance, as well as the role the Bcl-2:Beclin 1 complex in the switch between autophagy and apoptosis.
Insights
Cancer cells evade cell death through complex interactions between apoptosis and autophagy. The Bcl-2:Beclin 1 complex highlights how these pathways influence cancer progression and drug resistance.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Cancer cells develop resistance to chemotherapy by evading apoptosis and autophagy.
- Chemotherapeutics can target both apoptosis and autophagy, revealing pathway interdependencies.
- Proteins previously classified as solely autophagy-related or apoptosis-related are now known to influence both pathways.
Purpose of the Study:
- To review the intricate relationship between apoptosis and autophagy in cancer.
- To highlight the role of Bcl-2 and Beclin 1 in cancer development and drug resistance.
- To elucidate the function of the Bcl-2:Beclin 1 complex in switching between cell death pathways.
Main Methods:
- Literature review of key proteins and their roles in cell death pathways.
- Analysis of the interplay between autophagy and apoptosis.
- Focus on the Bcl-2:Beclin 1 complex as a regulatory hub.
Main Results:
- Proteins can dual-regulate apoptosis and autophagy, challenging previous classifications.
- The Bcl-2:Beclin 1 complex inhibits autophagy-associated cell death.
- Understanding these interactions is crucial for designing novel chemotherapeutics.
Conclusions:
- The Bcl-2:Beclin 1 complex is a critical regulator of cell fate decisions in cancer.
- Targeting the formation or disruption of this complex offers therapeutic potential.
- Further research into the interconnections of apoptosis and autophagy can overcome cancer drug resistance.
More Related Videos
09:10siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
11:39Assessing Autophagic Flux by Measuring LC3, p62, and LAMP1 Co-localization Using Multispectral Imaging Flow Cytometry
Published on: July 21, 2017
Related Concept Videos
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...